MA27502A1 - Derives de 1-n-phenylamino-1h-imidazole comme inhibiteurs de l'aromatase - Google Patents

Derives de 1-n-phenylamino-1h-imidazole comme inhibiteurs de l'aromatase

Info

Publication number
MA27502A1
MA27502A1 MA28355A MA28355A MA27502A1 MA 27502 A1 MA27502 A1 MA 27502A1 MA 28355 A MA28355 A MA 28355A MA 28355 A MA28355 A MA 28355A MA 27502 A1 MA27502 A1 MA 27502A1
Authority
MA
Morocco
Prior art keywords
phenylamino
imidazole derivatives
aromatase inhibitors
derivatives
relates
Prior art date
Application number
MA28355A
Other languages
English (en)
Inventor
Nathalie Adje
Paule Bonnet
Denis Carniato
Jean Lafay
Remi Delansorne
Jean-Claude Pascal
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02293107A external-priority patent/EP1431292A1/fr
Application filed by Theramex filed Critical Theramex
Publication of MA27502A1 publication Critical patent/MA27502A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Dérivés de 1-N-phénylamino-1H-imidazole comme inhibiteurs de l'aromatase THERAMEX La présente invention concerne des dérivés d'imidazole de formule : oé R1, R2, R3, R4, R5, R6 et n sont définis comme dans la description. L'invention concerne aussi des compositions pharmaceutiques contenant ces dérivés, et leurs utilisations.
MA28355A 2002-12-16 2005-06-22 Derives de 1-n-phenylamino-1h-imidazole comme inhibiteurs de l'aromatase MA27502A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43384102P 2002-12-16 2002-12-16
EP02293107A EP1431292A1 (fr) 2002-12-16 2002-12-16 Dérivés de 1-N-phénylamino-1H-imidazol et leur utilisation en tant qu'inhibiteurs d'aromatase

Publications (1)

Publication Number Publication Date
MA27502A1 true MA27502A1 (fr) 2005-08-01

Family

ID=42041569

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28355A MA27502A1 (fr) 2002-12-16 2005-06-22 Derives de 1-n-phenylamino-1h-imidazole comme inhibiteurs de l'aromatase

Country Status (23)

Country Link
EP (2) EP1431291A1 (fr)
JP (2) JP2004196795A (fr)
KR (1) KR20050084299A (fr)
CN (1) CN100390151C (fr)
AT (1) ATE325102T1 (fr)
AU (2) AU2003268835A1 (fr)
BR (1) BR0317339A (fr)
CA (1) CA2510175C (fr)
CY (1) CY1106317T1 (fr)
DE (1) DE60305069T2 (fr)
DK (1) DK1572665T3 (fr)
ES (1) ES2264032T3 (fr)
HK (1) HK1083218A1 (fr)
MA (1) MA27502A1 (fr)
MX (2) MXPA03011500A (fr)
NO (1) NO330337B1 (fr)
NZ (1) NZ540643A (fr)
PL (1) PL377095A1 (fr)
PT (1) PT1572665E (fr)
RU (1) RU2327691C2 (fr)
SI (1) SI1572665T1 (fr)
UA (1) UA80307C2 (fr)
ZA (1) ZA200504570B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2549603A1 (fr) * 2003-12-15 2005-06-30 Laboratoire Theramex Derives de 1-n-phenyl-amino-1h-imidazole et compositions pharmaceutiques les contenant
US20060288955A1 (en) * 2005-05-24 2006-12-28 Wyeth Device and method for controlling insects
TWI368505B (en) * 2005-05-24 2012-07-21 Wyeth Corp Versatile high load concentrate compositions for control of ecto-parasites
EP2499130A1 (fr) * 2009-11-11 2012-09-19 Bayer CropScience AG Nouveaux composés diazinyle-pyrazolyle
CN103275013A (zh) * 2013-05-27 2013-09-04 云南大学 一种新型含氮杂环磺酰胺衍生物型芳香化酶抑制剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232940A (en) * 1985-12-20 1993-08-03 Hatton Leslie R Derivatives of N-phenylpyrazoles
US6372774B1 (en) * 1985-12-20 2002-04-16 Rhone-Poulenc Agriculture Ltd. Derivatives of N-phenylpyrazoles
GB8531485D0 (en) * 1985-12-20 1986-02-05 May & Baker Ltd Compositions of matter
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5071861A (en) * 1986-03-07 1991-12-10 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
JP2500849B2 (ja) * 1991-09-02 1996-05-29 山之内製薬株式会社 トリアゾリル置換３級アミノ化合物又はその塩
UA41295C2 (uk) * 1991-09-02 2001-09-17 Яманугі Фармасетікл Ко., Лтд Триазолілзаміщені третинні амінні сполуки або їх солі як інгібітор ароматази та фармацевтична композиція на їх основі
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
CN1305857C (zh) * 2001-09-25 2007-03-21 巴斯福股份公司 杀虫和杀螨的3－取代吡唑

Also Published As

Publication number Publication date
EP1572665B1 (fr) 2006-05-03
AU2003298259B2 (en) 2009-04-02
CN1720235A (zh) 2006-01-11
JP2006511546A (ja) 2006-04-06
CA2510175C (fr) 2011-07-05
UA80307C2 (en) 2007-09-10
NO20052780L (no) 2005-06-08
RU2327691C2 (ru) 2008-06-27
AU2003298259A1 (en) 2004-07-09
DK1572665T3 (da) 2006-08-28
ES2264032T3 (es) 2006-12-16
ZA200504570B (en) 2006-08-30
EP1431291A1 (fr) 2004-06-23
CN100390151C (zh) 2008-05-28
BR0317339A (pt) 2005-11-08
EP1572665A2 (fr) 2005-09-14
SI1572665T1 (sl) 2006-10-31
RU2005122469A (ru) 2006-02-27
JP2004196795A (ja) 2004-07-15
DE60305069D1 (de) 2006-06-08
PT1572665E (pt) 2006-09-29
HK1083218A1 (en) 2006-06-30
DE60305069T2 (de) 2006-12-07
MXPA03011500A (es) 2004-09-10
CY1106317T1 (el) 2011-10-12
KR20050084299A (ko) 2005-08-26
NZ540643A (en) 2007-11-30
PL377095A1 (pl) 2006-01-23
NO330337B1 (no) 2011-03-28
AU2003268835A1 (en) 2004-07-01
ATE325102T1 (de) 2006-06-15
CA2510175A1 (fr) 2004-07-01
MXPA05006530A (es) 2006-02-17

Similar Documents

Publication Publication Date Title
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
DE60140695D1 (de) Anilinopyrimidinderivate als ikk?inhibitoren, und hiermit in zusammenhang stehende zusammensetzungen und verfahren
MA27560A1 (fr) Nouveaux derives de fluorglycoside heterocycliques, produits pharmaceutiques contenant ces composes et leur utilisation
TNSN07275A1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
MA29926B1 (fr) Derives de pyrazine
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
ATE228507T1 (de) Substituierte 6-phenylphenanthridine
ATE299890T1 (de) Inhibitoren von gamma-secretase
MA27728A1 (fr) Antagonistes des recepteurs de cgrp
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
DE60134874D1 (de) Benzodiazepin-derivate als gamma-secretase inhibitoren
MA28286A1 (fr) Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
TNSN02011A1 (fr) Derives de pyrimidine bicycliques nouveaux, inhibiteurs de mmp, et compositions les contenant
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
MA30296B1 (fr) Nouvelles amines
EE200100491A (et) Tetrahüdropüraani derivaadid, nende saamine ja kasutamine ravimainetena ning neid sisaldav farmatseutiline kompositsioon
MA27844A1 (fr) Derives pyrroliques substitues
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
ATE452896T1 (de) C3-cyanoepothilonderivate
MA27502A1 (fr) Derives de 1-n-phenylamino-1h-imidazole comme inhibiteurs de l'aromatase
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
DE602004011204D1 (de) Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
MA30292B1 (fr) Amines primaires comme inhibiteurs de la renine